Prolife Key Ratios
NSE: PROLIFE
₹80.50
₹1.50
(1.90%)
As on 28-Aug-2026IST
Market cap
₹33 Cr
Revenue (TTM)
₹55 Cr
P/E Ratio
7.7
P/B Ratio
0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -2.38 | -8.82 | 1.91 |
| EBIT | -- | -- | -56.83 | -1.74 | 0.18 |
| Net Profit | -- | -- | -46.59 | 2.84 | 2.98 |
| EPS | -- | -- | -46.59 | 2.84 | 2.98 |
| Book Value | -- | -- | 10.91 | 21.15 | 23.21 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 12.15 | 10.60 | 8.25 | 18.65 | 9.55 |
| Net Margin
| 10.57 | 8.98 | 8.13 | 15.00 | 8.59 |
| Return on equity
| 19.52 | 21.26 | 10.82 | 23.88 | 23.87 |
| Return on Capital
| 25.03 | 25.78 | 14.33 | 30.82 | 29.93 |
| Return on Assets
| 14.03 | 12.69 | 8.91 | 18.86 | 14.33 |
| Debt to Equity (x)
| -- | -- | 0.06 | 0.09 | 0.06 |
Profitability
ROCE
14.33
Higher than Peers by 2.27
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
14.33
|
30.82
|
29.93
|
22.56
|
31.27
|
|
Peer Median
|
12.06
|
13.53
|
--
|
21.96
|
20.41
|
ROE
10.82
Higher than Peers by 1.91
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
10.82
|
23.88
|
23.87
|
18.32
|
29.40
|
|
Peer Median
|
8.91
|
10.80
|
--
|
16.28
|
17.76
|
ROA
8.91
Higher than Peers by 3.27
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
8.91
|
18.86
|
14.33
|
8.27
|
13.05
|
|
Peer Median
|
5.64
|
6.79
|
--
|
12.29
|
10.41
|
EBIT Margin
8.25
Lower than Peers by 0.18
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
8.25
|
18.65
|
9.55
|
6.59
|
9.95
|
|
Peer Median
|
8.43
|
8.97
|
--
|
11.95
|
13.00
|
Net Margin
8.13
Higher than Peers by 2.17
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
8.13
|
15.00
|
8.59
|
5.75
|
7.44
|
|
Peer Median
|
5.96
|
6.62
|
--
|
9.57
|
9.41
|
Cash Profit Margin
10.41
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
10.41
|
17.55
|
10.43
|
7.46
|
8.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-2.38
Lower than Peers by 11.81
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
-2.38
|
-27.44
|
7.03
|
-0.24
|
45.37
|
|
Peer Median
|
9.42
|
9.36
|
--
|
29.50
|
44.59
|
EBIT Growth
-56.83
Lower than Peers by 58.62
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
-56.83
|
41.74
|
55.05
|
-33.92
|
60.97
|
|
Peer Median
|
1.79
|
-1.67
|
--
|
8.94
|
67.96
|
Net Profit Growth
-46.59
Lower than Peers by 45.50
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
-46.59
|
26.71
|
60.70
|
-21.77
|
36.16
|
|
Peer Median
|
-1.10
|
4.91
|
--
|
13.50
|
100.21
|
EPS Growth
-46.59
Lower than Peers by 46.74
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
-46.59
|
26.71
|
60.70
|
-21.77
|
36.16
|
|
Peer Median
|
0.15
|
4.91
|
--
|
--
|
100.20
|
Book Value Growth
10.91
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
10.91
|
26.69
|
26.55
|
19.54
|
33.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.06
Lower than Peers by 0.10
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
0.06
|
0.09
|
0.06
|
0.18
|
0.26
|
|
Peer Median
|
0.16
|
0.08
|
--
|
0.13
|
0.14
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
--
|
--
|
-0.07
|
-0.01
|
0.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.99
Higher than Peers by 4.77
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
6.99
|
4.95
|
4.28
|
1.22
|
1.12
|
|
Peer Median
|
2.23
|
2.18
|
--
|
1.93
|
1.82
|
Quick Ratio
5.56
Higher than Peers by 3.60
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
5.56
|
4.11
|
2.90
|
0.75
|
0.77
|
|
Peer Median
|
1.96
|
1.71
|
--
|
1.31
|
1.28
|
Interest Coverage
19.78
Higher than Peers by 10.93
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
19.78
|
36.41
|
22.63
|
13.53
|
15.12
|
|
Peer Median
|
8.85
|
10.17
|
--
|
14.41
|
11.56
|
Operating Efficiency
Debtors to sales
15.25
Lower than Peers by 3.08
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
15.25
|
9.43
|
13.54
|
22.91
|
21.54
|
|
Peer Median
|
18.32
|
17.58
|
--
|
17.99
|
15.79
|
Asset Turnover
1.06
Higher than Peers by 0.21
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
1.06
|
1.22
|
1.62
|
1.41
|
1.75
|
|
Peer Median
|
0.84
|
0.85
|
--
|
1.11
|
1.35
|
Receivable days
45.46
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
45.46
|
51.28
|
63.78
|
81.18
|
57.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
40.50
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
40.50
|
36.55
|
40.11
|
48.22
|
35.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
31.89
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
31.89
|
40.57
|
88.82
|
138.22
|
93.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
54.07
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
54.07
|
47.25
|
15.07
|
-8.83
|
-0.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
19.27
Lower than Peers by 16.17
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
19.27
|
9.90
|
--
|
15.78
|
3.77
|
|
Peer Median
|
35.43
|
34.02
|
--
|
27.79
|
30.46
|
Price / Book Value
1.98
Lower than Peers by 0.28
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
1.98
|
2.12
|
--
|
2.65
|
0.97
|
|
Peer Median
|
2.26
|
2.74
|
--
|
3.55
|
4.51
|
Dividend Yield
0.14
Lower than Peers by 0.16
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
0.14
|
0.24
|
--
|
0.18
|
0.59
|
|
Peer Median
|
0.30
|
0.28
|
--
|
0.36
|
0.22
|
EV/EBITDA
9.71
Lower than Peers by 13.96
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
9.71
|
5.15
|
0.42
|
9.36
|
2.87
|
|
Peer Median
|
23.67
|
19.92
|
--
|
19.44
|
27.85
|
Market Cap
90
Lower than Peers by 830
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Prolife
|
90
|
87
|
--
|
68
|
21
|
|
Peer Median
|
920
|
1,568
|
--
|
1,526
|
1,865
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
